NCT07244237

Brief Summary

The goal of this observational study is to investigate the correlation between self-reported pain and the measurements obtained using an artificial intelligence-assisted whole-body electrical stimulation device (StimaWELL 120MTRS system) in individuals with chronic back pain. The main question it aims to answer is: Is there any correlation between the pain intensity assessed with StimaWELL 120MTRS system, dolorimeter and self-report in adults with chronic back pain? The patients who have back pain for the duration longer than 3 months and have been eximaned by a medical doctor will be assessed with StimaWELL 120MTRS system, dolorimeter, and will be asked to rate their pain intensity in Numerical Pain Rating Scale.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 15, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

November 15, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 24, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2026

Completed
Last Updated

December 18, 2025

Status Verified

December 1, 2025

Enrollment Period

4 months

First QC Date

August 15, 2025

Last Update Submit

December 10, 2025

Conditions

Keywords

StimaWELL 120MTRS systemChronic Back PainMeasurement

Outcome Measures

Primary Outcomes (3)

  • Pain intensity measured by the StimaWELL 120MTRS system

    The StimaWELL® EMS device is a high-tech modulated low-frequency, 12-channel, mid-frequency stimulation device. The output of the calibration process will be recorded as data to use in the analysis.

    baseline, one time

  • Pressure pain threshold

    PPT will be assessed using a dolorimeter at four bilateral points (upper trapezius, lower trapezius, 5 cm lateral to L3 spinous process, and 2 cm cranial to the posterior superior iliac spine).

    baseline, pre-procedure

  • Patient-reported pain

    Participants will be asked to indicate the location of their back pain experienced over the last week on a body diagram, which shows the regions where the electrodes will be placed in a faint outline. For each marked region, participants will be asked to rate their pain intensity using the Numerical Pain Rating Scale. The scale ranges from 0 to 10, where 0 indicates "no pain" and 10 indicates "worst imaginable pain." Higher scores represent greater pain intensity.

    baseline, pre-procedure

Study Arms (1)

Patients with chronic back pain

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Participants will be recruited from the eligible and volunteer patients who will visit the healthy living center in study duration.

You may qualify if:

  • Experiencing back pain for more than three months
  • Experiencing recurrent back pain over the last week
  • Not having used analgesic or muscle relaxant medications in the last week
  • Aged between 18 and 60 years
  • Diagnosed with chronic low back pain by a medical doctor
  • Literate and able to cooperate with study procedures
  • Willing to participate in the study

You may not qualify if:

  • Having neurological, inflammatory, radiculopathy, vertebral fracture, or similar conditions
  • Experiencing acute-onset pain
  • Being pregnant or at risk of pregnancy
  • Having a psychiatric diagnosis and currently taking medication
  • Having a skin disease or lesion in the area where electrodes will be applied
  • Currently undergoing physical therapy
  • Having vestibular, auditory, or cognitive impairments
  • Possessing an electronic implant
  • Having a cardiac arrhythmia
  • Having a coronary or carotid stent
  • Being diagnosed with epilepsy
  • Having severe osteoporosis of the spine

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AMASYAŞAM Sağlıklı Yaşam Merkezi

Amasya, Turkey (Türkiye)

RECRUITING

Central Study Contacts

Aybike Şenel, Research Assistant, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 15, 2025

First Posted

November 24, 2025

Study Start

November 15, 2025

Primary Completion

March 15, 2026

Study Completion

March 15, 2026

Last Updated

December 18, 2025

Record last verified: 2025-12

Locations